I wanted to share this, because it asks for public comments, but I will warn you it is pretty tricky to follow (I glazed over repeatedly....). Read the parts in blue - that seems to be the new info they are addressing, very informative. I found this through rheumatology.org:
http://www.ncqa.org/Portals/0/PublicComment/Clinician_Level/Rheumatoid_Arthritis_Measures.pdf
The blue parts are a couple pages in, and a lot of the easier to understand comments are repeated with each measure.
I hope this link works, and I hope I chose the right title for the post from all the gobbedly-gook LOL.
It is from the National Committee for Quality Assurance and the American Medical Association.
The link worked for me, but it wouldn't let me copy/paste anything, sorry.
This is where I found it on rheumatology.org:
"RA Measures Public Comment Period Now Open
The ACR is collaborating with the AMA Physician Consortium for
Performance Improvement and the National Committee for Quality
Assurance on the development of new RA quality indicators based in part
on the revised RA guidelines. These measures are available for public
comment through July 1. To review the measures and learn more about
public comment, please visit the NCQA."
I wish I could copy/paste. The first measure is TB testing before biologics; apparently it isn't being done automatically across the board.
Each measure repeats the same things in several instances - less cases of RA, according to the census, rising cost of treatment due to biologics which are used by 25% of RA patients, out of pocket expenses for Medicare patients.
To submit comments, visit publiccomments.ncqa.org. Comments must be received by 5 p.m. (ET) July 1, 2008 to be considered.
Ooh, maybe copied links will work from here!